Key result
In STEMI patients with multivessel disease undergoing primary PCI, female gender was associated with higher unadjusted long-term mortality, but this difference lost significance after adjusting for baseline characteristics.
Why the study?
Does female gender affect long-term mortality in STEMI patients with multivessel disease undergoing primary PCI?
Cohort (n=832)
Does female gender affect long-term mortality in STEMI patients with multivessel disease undergoing primary PCI?
In STEMI patients with multivessel disease, apparent gender differences in long-term mortality are largely driven by baseline comorbidities and age rather than gender itself, though young women remain at disproportionately high risk.
Answers are grounded in this paper and cite their sources.
Comorbidities and age largely explain gender differences in STEMI mortality; leaves open whether young women need targeted strategies.
BACKGROUND: Gender and complete revascularisation are known to affect mortality. The objective of this study was to analyse a gender difference in mortality with respect to complete revascularisation for multivessel disease after primary percutaneous coronary intervention (PPCI) in ST-elevation myocardial infarction (STEMI) patients. METHOD: In a prospective consecutive cohort of 1472 patients presenting with STEMI for PPCI, between January 2006 and January 2010, 832 patients with multivessel disease were analysed. The primary outcome was long-term mortality. RESULTS: Median follow-up was 3.3 ± 1.2 years. Complete revascularisation was performed less in females than in males (30 vs. 38 %; p = 0.04). At PPCI, women (27 %, n = 221) were ± 10 years older (p = 0.001), had more hypertension, renal failure and symptoms of heart failure (all p < 0.01). Cumulative long-term mortality with incomplete revascularisation was higher in females (F: 30 vs. M: 15 %, p = 0.01). After adjustment for baseline characteristics, complete revascularisation (0.84; 95 % CI 0.54-1.32) and gender (1.11; 95 % CI 0.73-1.69) lost significance. Also the gender-by-complete revascularisation interaction was not significant at long term. In women, age under 60 years independently predicted higher mortality (HR 10.09; 95 % CI 3.08-33.08; p < 0.001). CONCLUSION: In STEMI patients with multivessel disease at PPCI, women under the age of 60 years had higher mortality, but in women older than 60 years comorbidity impacted the outcome of revascularisation strategy in the long term.
No takes yet. Share an insight, caveat, or question.
Ghauharali-Imami et al. (2015) conducted a cohort in ST-elevation myocardial infarction (STEMI) with multivessel disease (n=832). Female gender vs. Male gender was evaluated on Long-term mortality (HR 1.11, 95% CI 0.73-1.69, p=0.63). In STEMI patients with multivessel disease undergoing primary PCI, female gender was associated with higher unadjusted long-term mortality, but this difference lost significance after adjusting for baseline characteristics.
Synapse has enriched 10 related papers. Consider them for comparative context: